DSCM
ETON icon

Divisadero Street Capital Management’s Eton Pharmaceutcials ETON Stock Holding History

Divisadero Street Capital Management’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-298,000
Closed -$6.48M – 130
2025
Q3 		$6.48M Sell
298,000
-199,716
-40% -$3.31M 0.28% 67
2025
Q2 		$7.09M Buy
+497,716
New +$7.87M 0.45% 44

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

Divisadero Street Capital Management's ETON Position: Q4 2025 in Review

Divisadero Street Capital Management sold out of Eton Pharmaceutcials (ETON) in Q4 2025, closing a stake of 298,000 shares — an estimated $6.48M sold.

Divisadero Street Capital Management first reported a position in ETON in Q2 2025 and held it in 2 quarters. The position peaked at $7.09M in Q2 2025. 104 funds tracked by Wall St. Rank hold ETON as of Q4 2025.

  • Divisadero Street Capital Management reported no remaining Eton Pharmaceutcials position as of Q4 2025 after selling out during the quarter.
  • Divisadero Street Capital Management sold 298,000 Eton Pharmaceutcials shares in Q4 2025, an estimated $6.48M.
  • Divisadero Street Capital Management first reported a position in Eton Pharmaceutcials in Q2 2025 and held it in 2 quarters.
  • Divisadero Street Capital Management's Eton Pharmaceutcials position peaked at $7.09M in Q2 2025.
  • 104 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q4 2025.

Based on Divisadero Street Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.